Alnylam Pharmaceuticals (ALNY) EBIT Margin (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,101.00 |
| Dec 31, 2025 | -1,745.00 |
| Sep 30, 2025 | 3,156.00 |
| Jun 30, 2025 | -6,235.00 |
| Mar 31, 2025 | 7,799.00 |
| Dec 31, 2024 | -238.00 |
| Sep 30, 2024 | -2,272.00 |
| Jun 30, 2024 | 1,615.00 |
| Mar 31, 2024 | 1,769.00 |
| Dec 31, 2023 | -5,497.00 |
| Sep 30, 2023 | 10,060.00 |
| Jun 30, 2023 | -2,518.00 |
| Mar 31, 2023 | 938.00 |
| Dec 31, 2022 | 4,133.00 |
| Sep 30, 2022 | -1,237.00 |
| Jun 30, 2022 | -1,646.00 |
| Mar 31, 2022 | 645.00 |
| Dec 31, 2021 | 2,157.00 |
| Sep 30, 2021 | -3,056.00 |
| Jun 30, 2021 | 3,862.00 |
| Mar 31, 2021 | 1,385.00 |
| Dec 31, 2020 | 6,019.00 |
| Sep 30, 2020 | 1,234.00 |
| Jun 30, 2020 | 1,998.00 |
| Mar 31, 2020 | 20,457.00 |
| Dec 31, 2019 | -10,710.00 |
| Sep 30, 2019 | 21,968.00 |
| Jun 30, 2019 | 3,863.00 |
| Mar 31, 2019 | 48,063.00 |
| Dec 31, 2018 | 1.13 Mn |
| Sep 30, 2018 | -1.17 Mn |
| Jun 30, 2018 | 2,994.00 |
| Mar 31, 2018 | -28,470.00 |
| Dec 31, 2017 | 34,743.00 |
| Sep 30, 2017 | 2,033.00 |
| Jun 30, 2017 | -19,441.00 |
| Mar 31, 2017 | 9,959.00 |
| Dec 31, 2016 | 12,010.00 |
| Sep 30, 2016 | 28,009.00 |
| Jun 30, 2016 | 43,645.00 |
| Mar 31, 2016 | -27,284.00 |
| Dec 31, 2015 | 1,345.00 |
| Sep 30, 2015 | -39,873.00 |
| Jun 30, 2015 | -55,817.00 |
| Mar 31, 2015 | -9,140.00 |
| Dec 31, 2014 | 22,163.00 |
| Sep 30, 2014 | 20,498.00 |
| Jun 30, 2014 | 263,460.00 |
| Mar 31, 2014 | -297,872.00 |
| Dec 31, 2013 | 8,570.00 |
| Sep 30, 2013 | -11,318.00 |
| Jun 30, 2013 | -19,274.00 |
| Mar 31, 2013 | 98,742.00 |
| Dec 31, 2012 | -93,173.00 |
| Sep 30, 2012 | -5,050.00 |
| Jun 30, 2012 | -487.00 |
| Mar 31, 2012 | 1,351.00 |
| Dec 31, 2011 | -660.00 |
| Sep 30, 2011 | 381.00 |
| Jun 30, 2011 | 1,138.00 |
| Mar 31, 2011 | -1,646.00 |
| Dec 31, 2010 | -2,701.00 |
| Sep 30, 2010 | 1,213.00 |
| Jun 30, 2010 | 235.00 |
| Mar 31, 2010 | -1,572.00 |
| Dec 31, 2009 | 949.00 |
| Sep 30, 2009 | 5,131.00 |